CANSERA INC (CA)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2021
- $2.30M
- $2,304,939under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Nov 17, 2022
- SAM.gov registration
- Active
- Registration expiration date Sep 8, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- May 22, 2013 (13 years)
- Location
- Los Angeles, CA
- State of incorporation
- Delaware
- Purpose of registration
- All Awards
- Website
- cansera.com
† FY2026 obligations (provisional; DoD awards signed after Jul 28, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI KS4JGG27K1M6. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2021. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2022: $1,937,947
- FY2021: $366,992
Total across 2 fiscal years: $2,304,939
Top awarding agencies
- Department of Health and Human Services$2,304,939, 100%
Top awarding sub-agencies
- National Institutes of Health$2,304,939, 100%
Top NAICS by obligations
Top product and service codes by obligations
- AN12Health r&d services; health care services; applied research$2,304,939, 100%
Capabilities
NAICS codes
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Federal Capability Statement
Cansera, Inc. applies advanced technology to enhance cancer screening, monitoring, and treatment with the ultimate goal of improving patient outcomes. Our work centers on next-generation rare cell detection technologies powered by modern software architecture, machine learning, and AI-driven analytics. Our flagship platform, CellLogic, identifies and characterizes rare events from fluorescent whole slide imaging (fWSI) of human whole blood and other liquid biopsy samples, enabling highly scalable and clinically relevant insights.
Capabilities & Services
Contracts
Latest awards and orders
- 75N91021C00051Definitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for CANSERA INC lists a physical address and a separate mailing address, along with 5 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
1155 S GRAND AVE
LOS ANGELES, CA, 90015
USA
Mailing Address
1155 S Grand Ave
Ste 2001
Los Angeles, CA, 90015
USA
Government Business Contact
Peter Kuhn
President
1155 S GRAND AVENUE
#2001
Los Angeles, CA, 90015
USA
Electronic Business Contact
Peter Kuhn
President
1155 S GRAND AVENUE
#2001
Los Angeles, CA, 90015
USA
Past Performance Contact
Peter Kuhn
President
1155 S Grand Ave
#2001
Los Angeles, CA, 90015
USA
Government Business Alternate Contact
Elvia Nunez
Head of Finance & Operations
1155 S Grand Ave
#2001
Los Angeles, CA, 90015
USA
Electronic Business Alternate Contact
Elvia Nunez
Head of Finance & Operations
1155 S GRAND AVE
#2001
Los Angeles, CA, 90015
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
CANSERA INC has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires September 8, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in California with primary NAICS 541714
- Mapp Biopharmaceutical, Inc.San Diego, CA
- Terasaki Institute for Biomedical InnovationWoodland Hills, CA
- Gigagen IncSan Carlos, CA
- LA Jolla Institute for ImmunologyLa Jolla, CA
- Dnanexus, Inc.Mountain View, CA
- Hopo Therapeutics, Inc.Emeryville, CA